New azoles as first line therapy for Paecilomyces lilacinus in transplant patients

Transplant Infectious Disease

Volumn 10, Issue 2, 2008, Pages 149-150

  Garzoni, C ^b   Garbino, J ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CYTOCHROME P450; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; DRUG EFFICACY; DRUG METABOLISM; EYE MYCOSIS; GRAFT RECIPIENT; HUMAN; LETTER; MYCOSIS; PAECILOMYCES LILACINUS; PRIORITY JOURNAL;

ANIMALS; ANTIFUNGAL AGENTS; AZOLES; HUMANS; MYCOSES; PAECILOMYCES; TRANSPLANTATION; TREATMENT OUTCOME;

EID: 40849126779     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2007.00298.x     Document Type: Letter

References (9)

1. Van Schooneveld T, Freifeld A, Lesiak B, Kalil A, Sutton DA, Iwen PC. Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature. Transpl Infect Dis 2008 10 : 117 122.
2. Garbino J, Ondrusova A, Baglivo E, Lew D, Bouchuiguir-Wafa K, Rohner P. Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole. Scand J Infect Dis 2002 34 : 701 703.
3. Pastor FJ, Guarro J. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect 2006 12 : 948 960.
4. Chamilos G, Kontoyiannis DP. Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis. J Infect 2005 51 : e225 e228.
5. Martin CA, Roberts S, Greenberg RN. Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 2002 35 : e78 e81.
6. Gonzalez GM, Fothergill AW, Sutton DA, Rinaldi MG, Loebenberg D. In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi. Med Mycol 2005 43 : 281 284.
7. Groll AH, Walsh TJ. Posaconazole: clinical pharmacology and potential for management of fungal infections. Expert Rev Anti Infect Ther 2005 3 : 467 487.
8. Sansone-Parsons A, Krishna G, Martinho M, Kantesaria B, Gelone S, Mant TG. Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus. Pharmacotherapy 2007 27 : 825 834.
9. Mullane K, Toor AA, Kalnicky C, Rodriguez T, Klein J, Stiff P. Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections. Transpl Infect Dis 2007 9 : 89 96.